SparkLabs Supports Bio·Healthcare Startups with Partners Investment

Global accelerator SparkLabs announced on the 26th that it has signed a business agreement with Partners Investment to strengthen investment and support for startups in the bio and healthcare sectors.

Through this agreement, both companies plan to support early-stage startups in the bio and healthcare fields with ▲initial and follow-up investments ▲evaluation of technology commercialization potential ▲R&D consulting and commercialization strategies. Additionally, they will collaborate on establishing response strategies for regulatory environments in the bio and healthcare sectors, conducting joint research and providing consulting on national policy issues, and assessing and managing expected risks at each investment stage.

????????? ???????? is taking a commemorative photo with ???????? ?????????????????????? after signing the agreement.

Furthermore, both companies will support invested firms in moving into 'Medio Open Lab,' a shared laboratory co-operated by SparkLabs and the Korea Health Management Association, and provide access to over 17 million health checkup data records held by the Korea Health Management Association for research and development purposes. For startups that have successfully commercialized and established their business domestically, SparkLabs will support overseas market entry and securing local partnerships through its global network. They also plan to actively assist in attracting investments from foreign investors.

Kim Ho-min, CEO of SparkLabs, stated, “We expect to create the best synergy with Partners Investment, which has outstanding achievements in technology investment and corporate development in the pharmaceutical and healthcare sectors while managing funds totaling 1 trillion KRW.” He added, “Based on the expertise of both companies, we will discover and actively support capable early-stage startups.”

This content was produced with the assistance of AI translation services.